16-ID-203: A Multicenter, Double-Blind, Parallel-Arm, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects with Recurrence of Clostridium Difficile Infection

Grants and Contracts Details

StatusFinished
Effective start/end date5/16/174/15/20

Funding

  • Crestovo LLC: $13,510.00